ka.roos
Submits third-party assay reports on material purchased directly. Based in Zadar.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
98.66%
n=8
Suppliers covered
7
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042335 | L-Glutathione (reduced) | HJ | HJ-2511-F3082 | Janoshik | 2026-Q2 | 99.93 | 6.47 | — | Laboratory-retained | 0 | PASS |
| AX-2026-042719 | Retatrutide | GGPeps | GGPE-2511-W9618 | Janoshik | 2026-Q1 | 97.69 | 5.57 | 97.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019577 | Semaglutide | Homopeptide | HOMO-2509-F1941 | Kestrel | 2025-Q4 | 99.93 | 4.41 | 90.0 | Supplier-supplied | 2 | FAIL |
| AX-2025-021132 | Semaglutide | WXT | WXT-2509-A5382 | Janoshik | 2025-Q4 | 98.22 | 5.85 | 105.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018943 | NAD+ | FGP | FGP-2502-E1024 | Nordanalyt | 2025-Q3 | 99.93 | 11.30 | 92.8 | Supplier-supplied | 0 | FAIL |
| AX-2025-019463 | Retatrutide | Homopeptide | HOMO-2508-U9007 | VendorInvestigate | 2025-Q3 | 98.89 | 6.37 | 89.8 | Buyer-sourced | 2 | MARGINAL |
| AX-2025-020753 | IGF-1 LR3 | SGN | SGN-2409-D9887 | Janoshik | 2025-Q1 | 97.23 | 6.39 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019221 | Semaglutide | TFC | TFC-2502-L6365 | Janoshik | 2025-Q1 | 98.42 | 3.55 | — | Supplier-supplied | 1 | MARGINAL |